Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-18-054056

President and CEO sold 18,333 shares at $21.72 ($398,193)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2018-10-01 Sale −18,333 $21.72 $398,193 2,747,638 I
Open-market sales · 18,333 sh · avg $21.72 · $398,193
Loading xslF345X03/doc4.xml…